REFERENCES
- Chopra I, Hodgson J, Metcalf B, Poste G. To search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother 1997; 41: 497–503.
- Davies J. Inactivation of antibiotics and dissemination of resistance genes. Science 1994; 264: 375–382.
- Hawkey PM. The origins and molecular basis of antibiot-ic resistance. Br Med J 1998; 317: 657–60.
- Howard DH, Scott RD, Packard R, Jones DA. The glob-al impact of drug resistance. Clin Infect Dis 2003; 36 (Suppl 1): S4–10.
- Livermore DM. Bacterial resistance: origins, epidemiolo-gy, and impact. Clin Infect Dis 2003; 36 (Suppl 1): S11–23.
- Nicolau D. Clinical and economic implications of antimi-crobial resistance for the management of community-acquired respiratory tract infections. J Antimicrob Chemother 2002; 50 (Suppl 51): 61–70.
- O'Brien TF. Emergence, spread and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial any-where else. Clin Infect Dis2002; 34 (Suppl 3): s78–84.
- Wood MJ, Moellering RC. Microbial resistance: bacteria and more. Clin Infect Dis 2003;36 (Suppl 1): S2–3.
- Acar JF. Consequences of bacterial resistance to antibi-otics in medical practice. Clin Infect Dis 1997; 24 (Suppl. 1): S17-18.
- Felmingham D, Brown DFJ. Instrumentation in antimi-crobial susceptibility testing. J Antimicrob Chemother 2001; 48(Suppl 51): 81–5.
- Goossens H, Sprenger MJ W Community acquired infections and bacterial resistance. Br Med J 1998; 317, 6: 54–7.
- Kahlmeter G, DFJ Brown. Resistance surveillance stud-ies comparability of results and quality assurance methods. J Antimicrob Chemother 2002; 50: 775–77.
- Halls GA. The management of infections and antibiotic therapy: a European survey. J Antimicrob Chemother 1993; 31: 985–1000.
- Jones RN, Masterson R. Determining the value of antimicrobial surveillance programs. Diagn Microbiol Infect Dis 2001; 41: 171–175.
- Marchese A, Schito GC. Role of global surveillance in combating bacterial resistance. Drugs 2001; 61: 167–173.
- Felmingham D. The need for antimicrobial resistance surveillance. J Antimicrob Chemother 2002; 50 (Suppl 51): 1–7.
- Ferraro MJ, Jorgensen JH. Susceptibility testing instru-mentation and computerized expert systems for data analysis and interpretation. In: Murray P R et al.: Manual of Clinical Microbiology, Seventh Edition, ASM Press 1999: 1593–1600.
- Livermore D, Struelens M, Amorin J et al. Multicentre evaluation of the VITEK 2 advanced export system for inter-pretative reading of antimicrobial resistance tests. J Antimicrob Chemother 2002; 49: 289–300.
- Bert F, Branger C, Truchet A, Lambert-Zechovsky N. Evaluation of a new automated method for bacteriuria screen-ing. 7th Eur Congr Clin Microbiol Infect Dis, Vienna. 1995.
- Branca G, Franco A, Plaisant P, Fadda G, Archibusacci C. Applicazioni ed esperienze con lo strumento Uro-Quick all'interno di un laboratorio informatizzato di batteriologia. Igiene Mod 2001; 116: 219–228.
- Breda E. Principles and technology of the Uro-Quick system for bacteriuria rapid screening. Galeno 1996; 4: 11–21.
- Iverson D, Fayette R, Johnson C, Shigei J, Peterson E, Pezzlo M. Detection of bacteriuria by a rapid, three hours automated screening method. Abstr C-39 ASM. Chicago, USA, 1999.
- Sonak R, Thoholte H. Determination of the number of pathogens in bacterial suspection using laser nephelometry in comparison to the photometry and plate counting method. Zentralbl Bakteriol Mikrobio Hyg 1985; 260: 329–338.
- Soro O, Schito GC, Raggi M. Performance of a new automated method for the detection of bacteriuria. Abstr 1598, 7th ECCMID, Vienna, Austria, 1995.
- Roveta S, Balistreri MR, Marchese A, Debbia EA. Sistema rapido Uro-Quick per l'esecuzione di antibiogrammi: valutazione comparativa con il sistema Kirby-Bauer. Abstr 36,300. Congr Naz Soc It Microbiol, Catania, 2002.
- Roveta S, Debbia EA, Marchese A. Valutazione della sensibilita agli antibiotici di uropatogeni mediante sistema Uro-Quick direttamente sul campione di urine e confronto con il metodo Kirby-Bauer. GIMMOC 2003; 7: 67–74.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement: M100-512 Vol. 22. NCCLS Wayne, PA. 2002.
- Marchese A, Ramirez M, Schito GC, Tomasz A. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolated in Italy during 1993-1996. J Clin Microbiol, 1998; 36: 2944-49.
- Marchese A, Tonoli E, Debbia EA, Schito GC. Macrolide resistance mechanisms and expression of pheno-types among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother 1999; 44: 461–464.
- Chelossi E, Plate M, DeLeo C, Schito GC. Analisi genotipica di Streptococcus pyogenes eritromicino-resistenti isolati recentemente in Italia. GIMMOC 1998; 2: 9–20.
- Chelossi E, Plate M, De Leo C, Schito GC. Attivita di alcuni antibiotici su Streptococcus pyogenes eritromicino-resistenti isolati recentemente in Italia. GIMMOC 1997; 3: 9–20.
- Marchese A, Saverino D, Debbia EA, Pesce A, Schito GC. Antistaphylococcal activity of cefdinir, a new oral third generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. J Antimicrob Chemother 1995; 35: 53–66.
- Chung M, de Lencastre H, Matthews P, et al. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophhourssis: comparison of results obtained in a multilaboratory effort using identical pro-tocols and MRSA strains. Microb Drug Resist 2000; 6: 189–98.
- Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC. Multidrug-resistant Gram-positive pathogens: an update on current microbiological patterns. Drugs 1997; 54 (Suppl. 6): 11-20.
- Boisivon A, Thibault M, Leclercq R. Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clin Microbiol Infect 1997; 3: 175–9.
- Saverino D, Debbia EA Marchese A, Pesce A Botta GA, Schito GC. Plasmid loss from Gram-negative bacteria exposed to subinhibitory concentrations of g-lactam drugs and azithromycin. Microbiologica 1993; 16: 343–350.
- Marchese A, Arlet G, Schito GC, Lagrange PH, Philippon A. Detection of SHV-5 extended-spectrum beta-lac-tamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis 1996; 15: 245–8.
- Schito GC, Molinari G, Debbia EA, Shaw KJ, Sabatelli F, Hare RS, Miller CH. Mechanisms of aminoglycoside resis-tance in a large Italian hospital. Abstr A-67, 90th Annual Meeting ASM, 1990.
- Shaw K J, Rather P N, Hare RS, Miller CH. Molecular genetics of aminoglycoside resistance genes and familial rela-tionships of the aminoglycoside-modifying enzymes. Microbiol Rev 1993; 57: 138–163.